Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion Q4 Loss For Period Narrows To SEK 14.3 Mln

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    24/02/2022 07:40
    Feb 24 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH
QUARTER
AND FULL-YEAR 2021
    * Q4 OPERATING INCOME AMOUNTED TO 4,430 (5,277) KSEK.
    * Q4 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO -14,944
(-18,491)
KSEK.
    * Q4 LOSS FOR PERIOD AMOUNTED TO -14,320 (-17,353) KSEK

Source text for Eikon:  ID:nWkr3b1f9p 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news